The estimated Net Worth of Joanne B Bauer is at least $17.2 Million dollars as of 7 March 2023. Ms. Bauer owns over 19,329 units of Omnicell stock worth over $1,774,958 and over the last 19 years she sold OMCL stock worth over $15,110,755. In addition, she makes $299,972 as Independent Director at Omnicell.
Joanne has made over 26 trades of the Omnicell stock since 2006, according to the Form 4 filled with the SEC. Most recently she exercised 19,329 units of OMCL stock worth $493,469 on 7 March 2023.
The largest trade she's ever made was selling 67,578 units of Omnicell stock on 29 April 2012 worth over $5,297,439. On average, Joanne trades about 6,175 units every 106 days since 2006. As of 7 March 2023 she still owns at least 41,211 units of Omnicell stock.
You can see the complete history of Ms. Bauer stock trades at the bottom of the page.
Joanne B. Bauer is an Independent Director of Omnicell, Inc. Since October 2013, Ms. Bauer has served as a director of Omnicell since January 2014. Since October 2013, Ms. Bauer has served as a Director of Advocate Aurora Health, an integrated, not-for-profit, health care provider serving communities throughout eastern Wisconsin and northern Illinois. From October 2001 until June 2014, Ms. Bauer served as President of Global Health Care at Kimberly-Clark Corporation, a global consumer packaged goods company. Ms. Bauer joined Kimberly-Clark in 1981 and held various marketing and management positions within its adult care and health care businesses. Ms. Bauer received a B.A. degree from Lawrence University and an M.B.A. from the University of Wisconsin, Oshkosh.
As the Independent Director of Omnicell, the total compensation of Joanne Bauer at Omnicell is $299,972. There are 12 executives at Omnicell getting paid more, with Randall Lipps having the highest compensation of $7,208,970.
Joanne Bauer is 64, she's been the Independent Director of Omnicell since 2014. There are 3 older and 13 younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps, and Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: